Pernio after COVID-19 vaccination.
作者信息
Lopez S, Vakharia P, Vandergriff T, Freeman E E, Vasquez R
机构信息
University of Texas Southwestern Medical Center, Dallas, TX, USA.
Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
出版信息
Br J Dermatol. 2021 Aug;185(2):445-447. doi: 10.1111/bjd.20404. Epub 2021 May 31.
Abstract
摘要
相似文献
1
Pernio after COVID-19 vaccination.
Br J Dermatol. 2021 Aug;185(2):445-447. doi: 10.1111/bjd.20404. Epub 2021 May 31.
2
Pernio-like skin lesions after the second dose of Pfizer-BioNTech COVID-19 vaccine.
J Eur Acad Dermatol Venereol. 2021 Nov;35(11):e725-e727. doi: 10.1111/jdv.17500. Epub 2021 Jul 24.
3
COVID-19 Vaccination Safety in Patients who have had SARS-CoV-2-induced Chilblains.
Acta Derm Venereol. 2022 Jun 9;102:adv00728. doi: 10.2340/actadv.v102.888.
4
Chilblains After SARS-CoV-2 Vaccination: Coincidence or Real Association?
J Rheumatol. 2022 Nov;49(11):1295-1296. doi: 10.3899/jrheum.220487. Epub 2022 Aug 1.
5
Approach to Chilblains During the COVID-19 Pandemic.
J Cutan Med Surg. 2020 Sep/Oct;24(5):504-517. doi: 10.1177/1203475420937978. Epub 2020 Aug 3.
6
Cold and COVID: recurrent pernio during the COVID-19 pandemic.
Br J Dermatol. 2021 Jul;185(1):214-216. doi: 10.1111/bjd.19894. Epub 2021 Apr 18.
7
Acral chilblain-like lesions following inactivated SARS-CoV-2 vaccination.
Int J Dermatol. 2021 Sep;60(9):1152-1153. doi: 10.1111/ijd.15619. Epub 2021 Apr 26.
8
Chilblains and COVID-19-An Update on the Complexities of Interpreting Antibody Test Results, the Role of Interferon α, and COVID-19 Vaccines.
JAMA Dermatol. 2022 Feb 1;158(2):217-218. doi: 10.1001/jamadermatol.2021.5172.
9
Chilblains and COVID-19-An Update on the Complexities of Interpreting Antibody Test Results, the Role of Interferon α, and COVID-19 Vaccines-Reply.
JAMA Dermatol. 2022 Feb 1;158(2):218-219. doi: 10.1001/jamadermatol.2021.4449.
10
Comment on 'Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East': pernio unrelated to COVID-19.
Clin Exp Dermatol. 2020 Aug;45(6):752-754. doi: 10.1111/ced.14255. Epub 2020 May 24.
引用本文的文献
1
Chilblain-like lesion associated with coronavirus disease 2019 vaccine in tropical country: a case report.
J Med Case Rep. 2025 May 7;19(1):213. doi: 10.1186/s13256-025-05254-7.
2
Cases of Pernio-Like Lesions after mRNA-1273 Vaccination with Clinical and Pathological Features: A Single-Center Experience.
Ann Dermatol. 2023 Nov;35(Suppl 2):S281-S286. doi: 10.5021/ad.21.307.
3
Review of adverse events associated with COVID-19 vaccines, highlighting their frequencies and reported cases.
J Taibah Univ Med Sci. 2023 Sep 5;18(6):1646-1661. doi: 10.1016/j.jtumed.2023.08.004. eCollection 2023 Dec.
4
COVID-associated non-vasculitic thrombotic retiform purpura of the face and extremities: A case report.
Clin Case Rep. 2022 Dec 27;10(12):e6790. doi: 10.1002/ccr3.6790. eCollection 2022 Dec.
5
SARS-CoV-2 Vaccination and Chilblain-like Lesions: What Do We Know so Far?
Dermatol Pract Concept. 2022 Oct 1;12(4):e2022170. doi: 10.5826/dpc.1204a170. eCollection 2022 Nov.
6
Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature.
Clin Cosmet Investig Dermatol. 2022 Nov 6;15:2369-2382. doi: 10.2147/CCID.S388245. eCollection 2022.
7
Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin.
Curr Dermatol Rep. 2022;11(4):289-312. doi: 10.1007/s13671-022-00370-9. Epub 2022 Oct 17.
8
Similarity between cutaneous reactions due to SARS-CoV-2 and its vaccinations.
Future Virol. 2022 Sep. doi: 10.2217/fvl-2021-0357. Epub 2022 Sep 23.
9
COVID toes following vaccination.
Proc (Bayl Univ Med Cent). 2022 Mar 15;35(4):476-479. doi: 10.1080/08998280.2022.2043732. eCollection 2022.
10
Post-SARS-CoV-2 vaccination COVID toes and fingers : Two case reports and a short literature review.
Wien Med Wochenschr. 2023 Sep;173(11-12):267-269. doi: 10.1007/s10354-022-00944-z. Epub 2022 Jun 23.
本文引用的文献
1
Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.
J Am Acad Dermatol. 2021 Jul;85(1):46-55. doi: 10.1016/j.jaad.2021.03.092. Epub 2021 Apr 7.
2
'Blue toes' following vaccination with the BNT162b2 mRNA COVID-19 vaccine.
J Travel Med. 2021 Jun 1;28(4). doi: 10.1093/jtm/taab024.
3
Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic.
JAMA Dermatol. 2021 Feb 1;157(2):202-206. doi: 10.1001/jamadermatol.2020.4324.
4
COVID-19 vaccine BNT162b1 elicits human antibody and T1 T cell responses.
Nature. 2020 Oct;586(7830):594-599. doi: 10.1038/s41586-020-2814-7. Epub 2020 Sep 30.
5
The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series.
Br J Dermatol. 2021 Jan;184(1):141-150. doi: 10.1111/bjd.19415. Epub 2020 Sep 15.
6
The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries.
J Am Acad Dermatol. 2020 Oct;83(4):1118-1129. doi: 10.1016/j.jaad.2020.06.1016. Epub 2020 Jul 2.
7
SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases.
Br J Dermatol. 2020 Oct;183(4):729-737. doi: 10.1111/bjd.19327. Epub 2020 Aug 5.
8
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.
Br J Dermatol. 2020 Jul;183(1):71-77. doi: 10.1111/bjd.19163. Epub 2020 Jun 10.
Zotero 插件